STEER Act

Bill: 115-hr-6554
Sponsor: full_name: Rep. Kustoff, David [R-TN-8]
Introduced: 2018-07-26
Policy area: Crime and Law Enforcement
Subjects: Congressional oversight

Criminal justice information and records

Drug trafficking and controlled substances

Licensing and registrations
Latest action: action_date: 2018-10-01
text: Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Summaries:
action_date: 2018-07-26
action_desc: Introduced in House
text: <p><b>Substance Tableting and Encapsulating Enforcement and Registration Act or the STEER Act</b></p> <p>This bill amends the Controlled Substances Act to establish registration requirements for tableting machines and encapsulating machines.</p> <p>Specifically, the bill requires a person who possesses a tableting machine or encapsulating machine to obtain a registration from the Drug Enforcement Administration, subject to specified exceptions.</p> <p>Additionally, it prohibits and penalizes&#8212;with civil fines, criminal penalties, or both&#8212;the possession of an unregistered tableting machine or encapsulating machine.</p>

tv_txt: I 115th CONGRESS 2d Session H. R. 6554 IN THE HOUSE OF REPRESENTATIVES July 26, 2018 Mr. Kustoff of Tennessee (for himself and Ms. Kuster of New Hampshire ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Controlled Substances Act to require a person that possesses or intends to possess a tableting machine or encapsulating machine to obtain registration from the Attorney General, and for other purposes.

1. Short title This Act may be cited as the Substance Tableting and Encapsulating Enforcement and Registration Act or the STEER Act . 2. Registration for tableting and encapsulating machines (a) Persons required To register Section 302 of the Controlled Substances Act ( 21 U.S.C. 822 ) is amended— (1) in subsection (a), by adding at the end the following: (3) (A) Each person who possesses a tableting machine or encapsulating machine shall obtain from the Attorney General a registration for each such machine in accordance with regulations promulgated by the Attorney General. (B) Such person shall update the information submitted to the Attorney General for such registration as necessary to ensure the accuracy of such information. ; and (2) in subsection (c), by striking or list I chemical each place it appears and inserting , list I chemical, tableting machine, or encapsulating machine . (b) Registration process Section 303 of the Controlled Substances Act ( 21 U.S.C. 823 ) is amended by adding at the end the following: (l) Registration of tableting and encapsulating machines The Attorney General shall register each tableting machine or encapsulating machine for which an application is submitted under section 302(a)(3)(A) unless the Attorney General determines that such registration is inconsistent with the public interest. . (c) Definitions Section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ) is amended by adding at the end the following: (57) The term encapsulating machine means equipment— (A) that is designed to fill with a controlled substance, or a controlled substance analogue, a shell or capsule for human or animal consumption and that— (i) allows the operator of such equipment to fill more than one shell or capsule without human intervention between the filling of each such shell or capsule; or (ii) may be attached to a container that modifies such equipment such that the operator may fill more than one shell or capsule without human intervention between the filling of each shell or capsule; or (B) that has been used to fill with a controlled substance, or a controlled substance analogue, a shell or capsule for human or animal consumption. (58) The term tableting machine means equipment— (A) that is designed to compact or mold a controlled substance, or a controlled substance analogue, to produce a coherent, solid tablet for human or animal consumption and that— (i) allows the operator to produce more than one such tablet without human intervention between the production of each such tablet; or (ii) may be attached to a container that modifies such equipment such that the operator may produce more than one such tablet without human intervention between the production of each such tablet; or (B) that has been used to compact or mold a controlled substance, or a controlled substance analogue, to produce a coherent, solid tablet for human or animal consumption. . (d) Penalty Section 402(a) of the Controlled Substances Act ( 21 U.S.C. 842(a) ) is amended— (1) in paragraph (15), by striking or after section 310(e)(1)(B)(v); ; (2) in paragraph (16), by striking the period and inserting ; or ; and (3) by adding at the end the following: (17) to possess a tableting machine or encapsulating machine, in or affecting interstate commerce, without the registration required by this title. . (e) Application This section and the amendments made by this section shall apply beginning at the end of the one-year period following the date of the enactment of this Act. 3. Information campaign The Attorney General shall conduct a campaign to inform persons required to register under the amendments made by section 2 of such requirement. 4. Report Not later than 2 years after the date of the enactment of this Act, the Attorney General shall submit to the Congress a report containing— (1) a description and evaluation of the efforts of the Drug Enforcement Administration under the amendments made by section 2 to reduce the use of unregistered tableting machines and encapsulating machines in the illegal manufacture of controlled substances; (2) with respect to tableting machines and encapsulating machines, or disassembled parts of such machines— (A) the number seized by the Drug Enforcement Administration after the date of the enactment of this Act; and (B) the number imported and exported after the date of the enactment of this Act; and (3) recommendations with respect to changes to Federal law to support the Drug Enforcement Administration in such efforts.